Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors

Figure 12

Correlation between SETDB1 expression and immunoinhibitor, immunostimulatory, human leukocyte antigen- (HLA-) associated genes, microsatellite instability, and tumor mutational burden. (a) Immunoinhibitor, (b) immunostimulator, and (c) human leukocyte antigen- (HLA-) associated genes. Red color indicates positive correlations; blue color indicates negative correlations. (d) SETDB1 expression significantly correlated with immunoinhibitor and immunostimulator in KIRC tissues. (e) Microsatellite instability and (f) tumor mutational burden.

(a)

(b)

(c)

(d)

(e)

(f)